Showing results (101-110 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 11, 2003
Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeksAlison J Davis, Karen A Gelmon, Lillian L Siu, et al.
Investigational New Drugs|August 2, 2003
Clinical trial design for target specific anticancer agentsRonald Hoekstra, Jaap Verweij, Ferry A L M Eskens
Investigational New Drugs|November 16, 2019
The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participantsMaulik Patel, Joseph Chen, Stephanie McGrory, et al.
Investigational New Drugs|November 18, 2019
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumorsAlbiruni R Abdul Razak, Wilson H Miller, Geoffrey L Uy, et al.
Investigational New Drugs|January 26, 2019
Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcomaYi Luo, Anqi Zeng, Aiping Fang, et al.
Investigational New Drugs|December 1, 1988
Pyrazole: preclinical reassessmentP J O'Dwyer, S A King, J Plowman, et al.
Investigational New Drugs|June 1, 1988
Human leukocyte alpha interferon-induced transient neurotoxicity in childrenJ A Katz, D H Mahoney, C P Steuber, et al.
Investigational New Drugs|June 1, 1988
In vitro activity of amonafide against primary human tumors compared with the activity of standard agentsJ A Ajani, F L Baker, G Spitzer
Investigational New Drugs|June 1, 1988
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinomaP J Elson, L K Kvols, S E Vogl, et al.
Investigational New Drugs|November 9, 2019
Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trialWanqi Zhu, Hui Mei, Li Jia, et al.
Pageof 372